Skip to main content
Fig. 4 | Journal of Nanobiotechnology

Fig. 4

From: Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy

Fig. 4

In vivo biodistribution of multiple-targeting DPLGA@[RAW-4T1] NPs after intravenous injection. Typical bioluminescence (BLI) fluorescence images in vivo and ex vivo in model of breast cancer with lung metastasis. a BLI images of the same animal showed the progression of 4T1 metastasis in the lungs of mice. b Fluorescence images from each group were taken at 2, 4, or 8 h post-injection. c Ex vivo fluorescence images of tumor and organs collected from each group were taken 8 h post-injection. d Quantification of the ex vivo tumor and organ uptake of DiR and membrane-coated DiR NPs by imaging software (Bio-Real Sciences). Data are expressed as mean ± SD (n = 3)

Back to article page